葛兰素威康公司治疗急性肠炎的药物阿洛司琼( alosetron,Lotronex)首次获准在美国上市。阿洛司琼为一 5- HT3 受体拮抗剂 ,用于治疗妇女主要症状为腹泻的肠应激综合征 ( IBS)。预期将在 2 0 0 0年3月中旬在美国上市。在 1 0年内 ,阿洛司琼将为治疗 IBS的第一个新制剂。虽然 FDA Glaxo Wellcome Acute Enteritis Drugs Alosetron (Lotronex) First Approved for US Market. Alosetron is a 5-HT3 receptor antagonist for the treatment of irritable bowel syndrome (IBS) in women, the predominant symptom of which is diarrhea. It is expected to be available in the United States by mid-March 2000. Alosetron will be the first new preparation to treat IBS in 10 years. Although FDA